Navigation Links
Medbox, Inc. Weighs-in on FDA Evaluation of Prescription Medicine Dispensing Systems
Date:7/6/2012

HOLLYWOOD, Calif., July 6, 2012 /PRNewswire/ -- Medbox, Inc. (Pinksheets: MDBX) (www.medboxinc.com) recently offered some comments about the ongoing debate over how to implement self-service medication dispensing systems within pharmacies, and how to best maintain quality control, safety and security.

The FDA held a two-day hearing in March, where it heard from a variety of stakeholders on the public health implications of self-service prescription medicine dispensing. The purpose of the hearing was to evaluate the best ways to implement a prescription drug kiosk program "under conditions of safe use intended to ensure appropriate use by consumers, and (examine) the potential benefits and costs of this type of approach," according to Yolanda A. Fultz-Morris of the Center for Drug Evaluation and Research for the U.S. Food and Drug Administration.

"Medication-dispensing kiosks could be the next step in the hybrid of health care and self-service," according to a recent article on SelfServiceWorld.com. Patients already use kiosks to test their blood pressure, check-in for a doctor's appointment, and learn about health problems. Now, prescription medicine dispensing systems "are the next step in user-friendly health care," the article stated.

However, in contrast to many kiosk manufacturers that are trying to enter this emerging industry, Medbox differs greatly in their approach. The Medbox Rx system does not allow patients to self-diagnose, nor does it take the pharmacist out of the process, which are two of the biggest hurdles now facing the FDA's implementation of similar technology.

The Medbox Rx is a unique system that allows pharmacists to load a customer's medicine into a secure lockbox for later retrieval. The customer can pick up their medicine at their convenience through the self-service system by swiping their authorization card and placing their index finger on a scanner. Once the patient's identity has been verified, a lockbox door opens and they can access their medicine. 

The Medbox Rx system also maintains a permanent record of each operation, including a photograph of every person conducting a transaction, thereby increasing security while virtually eliminating fraud.

Because the system is designed to lighten the pharmacist's workload while increasing their capacity and enhancing the customer experience, it functions as a type of "Pharmacist's Assistant."

Other kiosk manufacturers are proposing that patients should be allowed to self-diagnose certain conditions and have the kiosk provide the medication, without ever consulting a doctor or pharmacist.

Medbox strongly opposes this idea, and believes that the best use of kiosk technology is to assist pharmacists while enhancing the customer experience by reducing wait times and increasing convenience.

About Medbox, Inc:  Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Tokyo, Connecticut, Arizona and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, urgent care centers, clinics, hospitals, and medical groups worldwide.

Medbox, Inc. is a publicly traded company, and is listed on the OTC Board, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.


'/>"/>
SOURCE Medbox, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medbox, Inc. Rides a Wave of Local Media Support in Connecticut
2. Phreesia identifies over 26% of patients who require additional autism evaluation
3. Partnership Aims to Prevent Students from Misusing Prescription Drugs
4. American Society of Hematology Statement on House Passage of Prescription Drug User Fee Act (PDUFA)
5. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
6. American Society of Hematology Statement on Senate Passage of Prescription Drug User Fee Act (PDUFA)
7. Parent Project Muscular Dystrophy Endorses Senate Version of Prescription Drug User Fee Act After Patient Voice Strengthened
8. Kmart® Launches New Pet Prescription Program And Purina® Treat Giveaway
9. Blue Cross Blue Shield of Michigan and Blue Care Network support the Drug Enforcement Administrations Nationwide Prescription "Drug Take-Back Day"
10. Polish Medicine Attracts Patients From Abroad - Not Only During EURO 2012
11. China Botanics Siberian Ginseng Extract Recognized as Safe Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... Oct. 4, 2017 OBP Medical ... illuminating medical devices, today announced regulatory approval from ... Agency (or Agência Nacional de Vigilância Sanitária (ANVISA)) ... cordless surgical retractor with integrated LED light source ... illumination and exposure of a tissue pocket or ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
(Date:10/12/2017)... ... 12, 2017 , ... On Saturday, October 21, the Health & Wellness Center ... to raise money for the American Heart Association Heart Walk. Teams of up to ... together to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
Breaking Medicine News(10 mins):